메뉴 건너뛰기




Volumn 106, Issue 2, 2010, Pages 188-193

Treatment failure and clinical progression after salvage therapy in men with biochemical recurrence after radical prostatectomy: Radiotherapy vs androgen deprivation

Author keywords

androgen deprivation; biochemical recurrence; clinical progression; prostate neoplasms; salvage radiation therapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

EID: 77953855202     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.09136.x     Document Type: Article
Times cited : (20)

References (17)
  • 1
    • 0034817278 scopus 로고    scopus 로고
    • Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience
    • Han M, Partin AW, Pound CR, Epstein JI, Walsh PC. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am 2001 28 : 555 565
    • (2001) Urol Clin North Am , vol.28 , pp. 555-565
    • Han, M.1    Partin, A.W.2    Pound, C.R.3    Epstein, J.I.4    Walsh, P.C.5
  • 2
    • 20444481754 scopus 로고    scopus 로고
    • Rising prostate-specific antigen after primary prostate cancer therapy
    • Ward JF, Moul JW. Rising prostate-specific antigen after primary prostate cancer therapy. Nat Clin Pract Urol 2005 2 : 174 182
    • (2005) Nat Clin Pract Urol , vol.2 , pp. 174-182
    • Ward, J.F.1    Moul, J.W.2
  • 3
    • 4143053657 scopus 로고    scopus 로고
    • Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: Long-term results
    • Roehl KA, Han M, Ramos CG, Antenor JA, Catalona WJ. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results. J Urol 2004 172 : 910 914
    • (2004) J Urol , vol.172 , pp. 910-914
    • Roehl, K.A.1    Han, M.2    Ramos, C.G.3    Antenor, J.A.4    Catalona, W.J.5
  • 4
    • 27244451002 scopus 로고    scopus 로고
    • Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy
    • Zhou P, Chen MH, McLeod D, Carroll PR, Moul JW, D'Amico AV. Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy. J Clin Oncol 2005 23 : 6992 6998
    • (2005) J Clin Oncol , vol.23 , pp. 6992-6998
    • Zhou, P.1    Chen, M.H.2    McLeod, D.3    Carroll, P.R.4    Moul, J.W.5    D'Amico, A.V.6
  • 5
    • 18844370372 scopus 로고    scopus 로고
    • Prostate-specific antigen velocity accurately predicts response to salvage radiotherapy in men with biochemical relapse after radical prostatectomy
    • Patel R, Lepor H, Thiel RP, Taneja SS. Prostate-specific antigen velocity accurately predicts response to salvage radiotherapy in men with biochemical relapse after radical prostatectomy. Urology 2005 65 : 942 946
    • (2005) Urology , vol.65 , pp. 942-946
    • Patel, R.1    Lepor, H.2    Thiel, R.P.3    Taneja, S.S.4
  • 6
    • 78649365001 scopus 로고    scopus 로고
    • Prostate specific antigen doubling time as a surrogate end point for prostate cancer specific mortality following radical prostatectomy or radiation therapy
    • D'Amico AV, Moul J, Carroll PR, Sun L, Lubeck D, Chen MH. Prostate specific antigen doubling time as a surrogate end point for prostate cancer specific mortality following radical prostatectomy or radiation therapy. J Urol 2004 172 : S42 6
    • (2004) J Urol , vol.172 , pp. 42-6
    • D'Amico, A.V.1    Moul, J.2    Carroll, P.R.3    Sun, L.4    Lubeck, D.5    Chen, M.H.6
  • 7
    • 0027979775 scopus 로고
    • Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer
    • Roach M 3rd, Marquez C, Yuo HS et al. Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer. Int J Rad Oncol Biol Phys 1994 28 : 33 7
    • (1994) Int J Rad Oncol Biol Phys , vol.28 , pp. 33-7
    • Roach III, M.1    Marquez, C.2    Yuo, H.S.3
  • 8
    • 0035003725 scopus 로고    scopus 로고
    • PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer
    • Roberts SG, Blute ML, Bergstralh EJ, Slezak JM, Zincke H. PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer. Mayo Clinic Proc 2001 76 : 576 581
    • (2001) Mayo Clinic Proc , vol.76 , pp. 576-581
    • Roberts, S.G.1    Blute, M.L.2    Bergstralh, E.J.3    Slezak, J.M.4    Zincke, H.5
  • 9
    • 45349084317 scopus 로고    scopus 로고
    • Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy
    • Trock BJ, Han M, Freedland SJ et al. Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy. JAMA 2008 299 : 2760 2769
    • (2008) JAMA , vol.299 , pp. 2760-2769
    • Trock, B.J.1    Han, M.2    Freedland, S.J.3
  • 10
    • 34249940817 scopus 로고    scopus 로고
    • Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy
    • Stephenson AJ, Scardino PT, Kattan MW et al. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol 2007 25 : 2035 2041
    • (2007) J Clin Oncol , vol.25 , pp. 2035-2041
    • Stephenson, A.J.1    Scardino, P.T.2    Kattan, M.W.3
  • 11
    • 0036890186 scopus 로고    scopus 로고
    • Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above
    • Kupelian PA, Buchsbaum JC, Elshaikh M, Reddy CA, Zippe C, Klein EA. Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above. Cancer 2002 95 : 2302 2307
    • (2002) Cancer , vol.95 , pp. 2302-2307
    • Kupelian, P.A.1    Buchsbaum, J.C.2    Elshaikh, M.3    Reddy, C.A.4    Zippe, C.5    Klein, E.A.6
  • 12
    • 33745236059 scopus 로고    scopus 로고
    • 25-year prostate cancer control and survival outcomes: A 40-year radical prostatectomy single institution series
    • Porter CR, Kodama K, Gibbons RP et al. 25-year prostate cancer control and survival outcomes: a 40-year radical prostatectomy single institution series. J Urol 2006 176 : 569 574
    • (2006) J Urol , vol.176 , pp. 569-574
    • Porter, C.R.1    Kodama, K.2    Gibbons, R.P.3
  • 13
    • 33847414931 scopus 로고    scopus 로고
    • Pathologic findings at radical prostatectomy: Risk factors for failure and death
    • Swanson GP, Riggs M, Hermans M. Pathologic findings at radical prostatectomy: risk factors for failure and death. Urol Oncol 2007 25 : 110 114
    • (2007) Urol Oncol , vol.25 , pp. 110-114
    • Swanson, G.P.1    Riggs, M.2    Hermans, M.3
  • 14
    • 1842634674 scopus 로고    scopus 로고
    • Prognostic indicators for long term outcome following radical retropubic prostatectomy for prostate cancer involving the seminal vesicles
    • Johnson CW, Anastasiadis AG, McKiernan JM et al. Prognostic indicators for long term outcome following radical retropubic prostatectomy for prostate cancer involving the seminal vesicles. Urol Oncol 2004 22 : 107 111
    • (2004) Urol Oncol , vol.22 , pp. 107-111
    • Johnson, C.W.1    Anastasiadis, A.G.2    McKiernan, J.M.3
  • 15
    • 58649103315 scopus 로고    scopus 로고
    • Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): An open randomised phase III trial
    • Widmark A, Klepp O, Solberg A et al. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial. Lancet 2009 373 : 301 308
    • (2009) Lancet , vol.373 , pp. 301-308
    • Widmark, A.1    Klepp, O.2    Solberg, A.3
  • 16
    • 33751018522 scopus 로고    scopus 로고
    • Adjuvant radiotherapy for pathologically advanced prostate cancer: A randomized clinical trial
    • Thompson IM Tangen CM, Paradelo J et al. Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial. JAMA 2006 296 : 2329 2335
    • (2006) JAMA , vol.296 , pp. 2329-2335
    • Thompson, I.M.1    Tangen, C.M.2    Paradelo, J.3
  • 17
    • 23744493443 scopus 로고    scopus 로고
    • Postoperative radiotherapy after radical prostatectomy: A randomised controlled trial (EORTC trial 22911)
    • Bolla M, van Poppel H, Collette L et al. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet 2005 366 : 572 578
    • (2005) Lancet , vol.366 , pp. 572-578
    • Bolla, M.1    Van Poppel, H.2    Collette, L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.